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Background: Four major genotypes of hepatitis E virus (HEV), the causative agent of hepatitis E, have so far been
recognized. While genotypes 3 and 4 are both zoonotic, the disease symptoms caused by the latter tend to be
more severe. To examine if specific nucleotide/amino acid variations between genotypes 3 and 4 play a role in
determining the severity of hepatitis E disease, the complete genome of one swine HEV genotype 4 isolate,
SAAS-FX17, was determined and compared with other genotype 4 and genotype 3 genomes to identify putative
HEV genotype 4 virulence determinants.
Results: A total of 42 conformable nt/aa variations between genotype 3 and 4 HEVs were detected, of which
19 were proposed to be potential disease severity determinants for genotype 4 strains.
Conclusions: One potential determinant was located in each of the 5'-UTR and 3'-UTR, 3 and 12 within ORF1 and
ORF2 respectively, and 2 in the junction region.
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Hepatitis E virus (HEV) is an important human patho-
gen in many regions of the world, and is the causative
agent of acute hepatitis, a disease spread mainly through
fecal contamination of water supplies or food [1]. HEV
is the sole member of the genus Hepevirus of the family
Hepeviridae [2]. The virus is a single-stranded positive-
sense RNA virus containing a short 5' untranslated
region (UTR), three open reading frames (ORF1-3), and
a 3' UTR [3]. ORF1 encodes non-structural proteins
involved in viral replication, ORF2 encodes a structural
protein comprising the virion capsid, and ORF3, which
overlaps ORF2, is required for viral egress from infected
cells [4].* Correspondence: zhenli60@163.com
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reproduction in any medium, provided the orFour major HEV genotypes and several subtypes
within each genotype have been identified in mammalian
species [5]. Genotypes 1 and 2 have been isolated from
humans only and genotypes 3 and 4 are zoonotic [6].
Evidence is accumulating to indicate that different
HEV genotypes are associated with disease symptoms of
differing severity. For example, genotypes 3 and 4 appear
to be less virulent for humans compared with geno-
types 1 and 2 [7]. Furthermore, disease symptoms
caused by genotype 4 are reported to be more severe
compared with genotype 3 infections [8-10], and geno-
type 4 viral loads recorded in a co-infected patient were
also higher [11].
In order to identify specific nucleotides/amino acids
influencing the severity of HEV infections, we have now
determined the full genome sequence of swine HEV
strain, SAAS-FX17, which was previously classified as a
genotype 4, sub-type (i) virus [12]. Potential determi-
nants responsible for the observed variations in the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Zhu et al. Virology Journal 2012, 9:264 Page 2 of 7
http://www.virologyj.com/content/9/1/264severity of disease symptoms caused by genotype 3 and
4 strains were then identified by comparison with the
corresponding sequences of 56 genotype 4 and 56 geno-
type 3 HEV’s retrieved from GenBank.
Materials and methods
Fecal specimens and extraction of RNA
Swine HEV, strain SAAS-FX17, was isolated from a fecal
specimen collected in 2008 from a pig farm located in a
Shanghai suburb. Sample treatment and total RNA ex-
traction procedures were described previously [13].
Reverse transcription and PCR
All the non-terminal reverse transcripts (RTs) were
synthesized with the SuperScript™ III First-strand
Synthesis System (Invitrogen, USA) using an external
antisense primer, and the first-strand cDNA was used
immediately for PCR.
Ten sets of specific external and internal primer pairs
(see Additional file 1: Table S1) were used to amplify theFigure 1 Phylogenetic tree depicting the genotypic/subgenotypic sta
sequence. Internal node numbers indicate the bootstrap values as a perceentire viral genome. Nucleotide (nt) sequences at the 5'
and 3' ends were determined with the SMARTTM Rapid
Amplification of cDNA Ends (RACE) cDNA Amplifica-
tion Kit (Clontech Laboratories, Japan) according to the
manufacturer’s instructions.
Sequence analysis
PCR products were purified and ligated into a pJET 1.2/
blunt cloning vector (Fermentas). At least three positive
clones were selected at random and sequenced (Sangon
Biotech Shanghai Co., Ltd) in both directions using an
ABI model 3730 automatic DNA sequencer (ABI, CA,
USA).
Sequence assembly was accomplished and percent
identity values were calculated using Lasergene (version
7.10; DNAstar). Sequence alignments were generated by
Clustal-W (version 1.8). Phylogenetic trees were con-
structed by the neighbor-joining method with the aid of
the MEGA 4.0 software package. Genetic distances were
calculated by using the Kimura two-parameter method.tus of 30 HEV isolates based on the full length genomic
ntage of trees obtained from 1000 replicates.
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culate branch percentage values. Secondary structures in
the 5' UTR were predicted with the mfold program [14].
Nucleotide sequence accession number
The full genomic nucleotide sequence of strain SAAS-
FX17 has been deposited in the GenBank database under
accession number JF915746. Accession numbers and
classifications of the 120 HEV reference strains are shown
in Additional file 2: Table S2. Of these, 30 complete
HEV genome sequences were selected at random in order
to construct the genotype/subtype phylogenetic tree
(Figure 1). All nt and amino acid (aa) comparisons are
made with reference to strain SAAS-FX17.
Results
Genome organization of swine HEV strain SAAS-FX17
The full-length genome of strain SAAS-FX17 consisted
of 7262 nt, excluding the poly (A) tail at the 3' terminus,
and contained three ORFs. The genome was organized
into a 5' UTR extending from nt 1–26, ORF1 from nt
27–5135 (5109 nt), ORF2 from 5174–7156 (1983 nt),
and a smaller ORF3 (which overlapped ORF2) from
5166–5504 (339 nt). The 77 nt 3' UTR extended
from 7157 to 7233 and was followed by a poly (A) tail of
29 A residues.Figure 2 Secondary structures of the 5'-UTR region of HEV genotypes
Arrows indicates the nucleotide variation between the different genoPhylogenetic analysis
The nt sequence of SAAS-FX17 was 74.5-75.7% similar
to all recorded HEV genotypes 1–3 and was 83.7-94.8%
identical with the genome sequences of all reported
genotype 4 HEVs. Consistent with an earlier classifica-
tion [12], SAAS-FX17 was confirmed as belonging
to subtype 4i within genotype 4 (Figure 1). Sequence
similarity with other viruses within this subgroup was
90.6-94.8%, and 84.0-85.6% with members of the other
genotype 4 sub-groupings (4a-4h).
The SAAS-FX17 genome is most closely related to
that of a human HEV strain, E067-SIJ05C, derived from
an acute hepatitis E patient in Japan, who had traveled
to Shanghai prior to the onset of disease symptoms.
These two isolates shared nt similarities of 94.8%, 94.6%,
95.1% and 97.6% in terms of the full-length genome,
ORF1, ORF2 and ORF3, respectively.
5' UTR and 3' UTR analyses
The 5' UTR of SAAS-FX17 consisted of 26 nt and con-
tained one additional G at the extreme 5' terminus com-
pared with the majority of genotype 4 strains. One
unique nt substitution (C23T) was identified in the sec-
ond loop structure of the 5' UTR of genotype 4 HEV
strains which, as seen in Figure 2, contained eight nts
compared with six for genotype 3 strains.3 (A) and genotypes 4 (B), as predicted by the mfold program.
types.
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excluding the poly (A) tail but including five additional
nts (ACTGGT) at the terminus. 3' UTRs of all genotype
4 strains contained an initial TTTATT sequence as




The ORF1 of SAAS-FX17 consisted of 5109 (27–5135)
nts capable of encoding a protein of 1702 aa. The nu-
cleotide and amino acid sequences were 82.5-94.6% and
93.1-98.2% identical, respectively to the corresponding
sequences of other genotype 4 isolates.
Excluding the hypervariable region (HVR), 12 geno-
type 4 specific aa substitutions were identified in the
ORF1 (Table 1). Two aa variations were evident in the
HVR, the initial conserved sequence of which was
VSGFSSCFSP in genotype 4 strains compared with
TSGFSSDFSP in genotype 3 strains (Table 1).
ORF2
The ORF2 of SAAS-FX17 consisted of 1983 nts capable
of encoding a protein of 660 aa. The nucleotide and
amino acid sequences were 86.7-95.1% and 93.9-99.1%
identical, respectively to the corresponding sequences of
other genotype 4 isolates. Comparison of the ORF2 pro-
teins in the two HEV genotypes revealed a total of 18 aa
substitutions (Table 1).
ORF3
The ORF3 of SAAS-FX17 consisted of 345 nts, encoding
114 aa. The nucleotide and amino acid sequences were
91.3-98.8% and 90.3-97.7% identical, respectively to the
corresponding sequences of other genotype 4 isolates.
The ORF3-encoded protein of genotype 4 strains con-
tained two aa insertions (5P, 84Q) and one aa deletion
(aa residue 68), an additional aa overall compared with
genotype 3 viruses. Furthermore, there was an a substitu-
tion (A35V) when compared with genotype 3 (Table 1).Table 1 Specific amino acid substitutions/insertions/
deletions in the ORF1-3 regions of HEV genotype 4
strains
Region Amino acid variation and site
ORF1 Substitutions: Q486E, R491L, E494D, A501E, F502P/L/E, E503A/V,
S505L/V/I/F, D508S, P509G, A510T/S, T/A524H/Y/T, D1574N
HVR Substitutions: T707V, D713C
ORF2 Substitutions: I66V, P/S67V/F/L, T/A68S/P, A/T69Q, T/A70S/P,
P/S97A/T/V, A114S, T/A146S, I147V, T149S/A, S161N, S324T,
S/G326T, K330R, G509A, C580A, N587S, S590A
ORF3 2 aa insertions (5P, 84Q) , 1 aa substitution (A35V) and 1 aa
deletion (aa residue 68)Junction region (JR)
The JR[15] of SAAS-FX17 consisted of 38 bp, which is
identical in length to most other genotype 4 strains but
4 bp longer than the corresponding region of genotype 3
strains. These additional 4 bp were due to 4 nt insertions
at sites 10, 30, 31 and 32 of the JR. The space length
(distance between the ORF2 and ORF3 initiation sites)
was 11bp and 8bp for genotypes 4 and 3, respectively
(Figure 3).
Discussion
Since 2000, genotype 4 HEV has replaced genotype 1 as
the dominant cause of hepatitis E in China [16-18]. Re-
cently, Zhu et al. [12] identified a novel virus belonging
to subtype 4i, the same subtype to which SAAS-FX17
has been assigned. In view of the close relationship be-
tween SAAS-FX17 and strain E067-SIJ05C, derived from
an acute hepatitis E patient in Japan who had traveled to
Shanghai before the onset of disease symptoms, it
appears HEV strains belonging to this subtype may
undergo zoonotic transmission.
Zhang et al. [19] previously suggested that the 5' UTR
of the viral genome may play an important role in repli-
cation and/or translation. Other researchers reported
that the 5' UTR and a conserved 58 nt region within
ORF1 were likely to fold into conserved stem-loop and
hairpin structures, which were postulated to be import-
ant for HEV RNA replication [20]. In the present study,
a unique nt substitution, C23T, was identified within the
putative stem-loop structure of the 5' UTR, which
resulted in a change in the size of the second loop. Pre-
vious studies have shown that nt variations in the central
portion of the 5' UTR may influence the severity of type
A hepatitis [21]. However, although a potential virulence
determinant for genotype 4 HEV, the impact of C23T on
HEV disease symptoms remains to be established.
The 3' UTR and an adjacent region of the HEV gen-
ome form a putative stem-loop structure that affects the
binding of recombinant viral RNA dependent RNA poly-
merase (RdRp) and initiation of RNA synthesis [22].
Graff et al. [23] showed that a seemingly minor change
caused by a mutation at nt 7106, which eliminated one
putative base pair within the stem-loop, significantly
inhibited RNA replication, and the magnitude of virus
replication could be the reason for the severity difference
of HEV. Therefore, based on these previous research
findings, a single nt difference (T3A) identified between
the 3' UTR sequences of HEV genotypes 3 and 4 also
represents a putative virulence determinant.
HEV ORF1 encodes a large nonstructural protein with
several putative functional motifs [24]. Our data derived
from sequence comparisons of this region in HEV geno-
types 3 and 4 revealed 12 specific aa substitutions, 11 of
which occurred in the protease motif. However, since no
Figure 3 Alignment of nucleotide sequences comprising the junction region (JR) of genotype 3 strains (below the line) and genotype
4 strains (above the line). The first and second boxed ATG triplets constitute the ORF2 and ORF3 start codons, respectively. Deletions are
indicated by dashes, identical nucleotides by dots, and insertion sites by ^. The strains were selected to represent all the genomic variations
within the JR region of genotypes 3 and 4 HEV.
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been attributed to this enzyme, these substitutions are
unlikely to have a role as virulence determinants. The
remaining substitution was located in the RdRp motif,
which is essential for genomic RNA replication. In
addition, two aa variations were recorded in the
conserved initiation motifs of the HVRs of genotype 3
and 4 strains. Virus attenuation that accompanied
complete deletion of this region of ORF1 led to the sug-
gestion that the HVR played a biological role in HEV
pathogenesis [25]. Therefore, we propose that these two
variations together with the substitution in the RdRp
motif are potential candidates for virulence variation in
type 4 HEV.
ORF2 encodes the viral capsid protein, including a sig-
nal peptide (aa 1–22) involved in the translocation of
the protein from the endoplasmic reticulum [26], and an
arginine-rich domain (aa 23–111) that may be involved
in RNA encapsidation [27]. Córdoba et al. [28] recently
verified that mutations within the latter domaincontributed to virus attenuation. Our data comparing
HEV genotypes 3 and 4 identified six specific aa subs-
titutions within this region, five of which (aa residues
66–70) were continuous. This entire sequence motif
may represent a single putative virulence determinant
[16], implying the possible existence of two such deter-
minants in the entire arginine-rich region. Three struc-
tural domains have been defined within the C-terminus
of the HEV capsid: S (residues 118–313), P1 (residues
314–453) and P2 (residues 454–606), which function in
forming the capsid shell, binding of the virus to host cell
receptors, and antigenicity, respectively [29,30]. Single or
multiple variations in the aa sequences of the capsid or
envelope proteins resulted in attenuated viral pheno-
types [31,32] and, more recently, Córdoba et al. [28]
verified that HEV attenuation was also linked to muta-
tions in the P1 domain. Our study revealed four, three
and four specific substitutions in the S, P1 and P2
domains, respectively of genotype 4 HEV. Each might
constitute individual putative virulence determinants
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147 could represent a single influencing factor.
ORF3 protein is essential for virion release from HEV
infected cells [33]. However, it remains unclear if differ-
ences in the length of the ORF3 regions of HEV geno-
types 3 and 4, or specific aa variations in the encoded
proteins, influence the severity of the respective clinical
symptoms.
The Junction Region (JR) denotes the genome segment
between the stop codon of ORF1 and the putative initi-
ation codon of ORF2, in which a bicistronic subgenomic
mRNA encodes both ORF2 and ORF3 proteins of HEV
[15]. Cao et al. [34] demonstrated that nt mutations or a
mutation in the stem-loop structure formed within the
JR significantly inhibited HEV replication. Furthermore,
Shukla et al. [35] reported that the distance between the
initiation codons of ORF2 and ORF3 affected initiation
preferences. Therefore, nt mutations and distance vari-
ation between the ORF2 and ORF3 initiation codons
within the JR of genotypes 3 and 4 may constitute strong
candidates for determinants of disease severity. Although
four nt insertions at sites 10, 30, 31 and 32 of the JR
were identified in this study, the contiguous insertions at
positions 30–32 may represent a single putative viru-
lence determinant.Conclusions
A total of 42 nt/aa variations between HEV genotypes 3
and 4 were identified. Not all may constitute potential
virulence determinants since several observed contiguous
nt/aa variations, which are often responsible for a single
mutation incident [16,36], may each constitute a single de-
terminant. Based on this conjecture, the 42 nt/aa varia-
tions represented 19 potential determinants. However, the
possibility of additional putative determinants existing
among the 42 variations cannot be excluded.Additional files
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